Wilder-Ortiz match set for March 3 in Brooklyn

Deontay Wilder to fight Luis Ortiz in March

Wilder-Ortiz match set for March 3 in Brooklyn

Four months after being pulled from his heavyweight title bout against Deontay Wilder for failing a drug test, fellow unbeaten Luis Ortiz will get a second chance at the WBC championship.

Ortiz avoided a ban after the WBC found he had taken diuretics for high blood pressure, although he was fined.

Showtime will produce the event and will televise it either on Showtime or on sister network CBS.

Mother of "swatting" victim wants cop criminally charged for shooting
The Wichita Eagle reported that Wichita Police Chief Gordon Ramsay vowed Tuesday for a "thorough review" of Finch's death. The caller repeatedly gave authorities his alleged home address, leading Wichita police officers to the house.

He and Ortiz were initially supposed to fight on that card, but the Cuban was scratched because of a positive drug test.

Wilder, 32, was then present when Ortiz stopped the lightly-regarded Daniel Martz in December, and that night told him: "I've been wanting you".

After Ortiz's victory, Wilder entered the ring and faced off with him in a colorful exchange that was captured on the FS1 telecast. We must fight each other. So I'm going to bless you again with a second opportunity.

Institutional Investor Sentiment About General Motors Co (NYSE:GM) Improved
After $2.72 actual EPS reported by The Boeing Company for the previous quarter, Wall Street now forecasts 5.51% EPS growth. The firm has a market capitalization of $62,410.00, a P/E ratio of 9.56, a P/E/G ratio of 0.82 and a beta of 1.55.

"I'm always a man of my word. But this time no excuses".

The victor of the contest could very well land themselves an opportunity against the victor of Anthony Joshua v Joseph Parker in a contest for all the belts available in the heavyweight division, with the proposed clash anticipated set for the March 31st in Cardiff.

Wilder (39-0, 38 KOs) is coming off a first-round knockout of Bermane Stiverne in November.

Analysts Ratings on: Momenta Pharmaceuticals Inc. (MNTA)
BidaskClub cut Momenta Pharmaceuticals from a "buy" rating to a "hold" rating in a research note on Thursday, December 7th. Finally, Rhumbline Advisers lifted its position in shares of Momenta Pharmaceuticals by 8.6% during the 2nd quarter.

Últimas notícias